<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02470416</url>
  </required_header>
  <id_info>
    <org_study_id>HREC/14/WMEAD/226(4028)</org_study_id>
    <nct_id>NCT02470416</nct_id>
  </id_info>
  <brief_title>Prevalence of Small Bowel Polyps in Patients With Sporadic Duodenal Adenomas</brief_title>
  <acronym>SPIDA</acronym>
  <official_title>A Prospective Case Control Study on the Prevalence of Small Bowel and Colonic Polyps in Patients With Duodenal Adenomas/Ampullomas Who do Not Have Familial Adenomatous Polyposis (FAP) or Peutz Jeghers Syndrom (PJS).</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Western Sydney Local Health District</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Westmead hospital Westmead NSW 2145 Australia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Western Sydney Local Health District</source>
  <brief_summary>
    <textblock>
      Little is known about the prevalence of small bowel polyps in patients with sporadic&#xD;
      Duodenal/Ampullary polyps. The investigators aim to investigate the prevalence of small bowel&#xD;
      polyps in patients with sporadic (ie not related to FAP or PJS) duodenal/ampullary adenomas&#xD;
      by performing small bowel capsule endoscopy and comparing the results to those acquired from&#xD;
      a control cohort undergoing VCE for accepted indication at our centre.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Investigation for suspected SB tumors is an acceptable indication for VCE. SB polyps occur&#xD;
      frequently in patients with FAP/PJS and in patients with FAP, they are significantly more&#xD;
      common in patients with Duodenal/Ampullary polyps. Little is known about the prevalence of&#xD;
      small bowel polyps in patients with sporadic Duodenal/Ampullary polyps.&#xD;
&#xD;
      The primary hypothesis is that patients with sporadic (ie not related to FAP or PJS)&#xD;
      duodenal/ampullary adenomas have a higher prevalence of small bowel polyps compared with&#xD;
      patients undergoing VCE for various indications who have not had a duodenal polyp diagnosed&#xD;
      or removed.&#xD;
&#xD;
      Patients who have had a previous diagnosis and/or treatment of a duodenal/ampullary polyp at&#xD;
      Westmead hospital will receive VCE examination. Control population will consist of age&#xD;
      matched controls having VCE for OGIB/IDA at Westmead hospital. Patients will be required to&#xD;
      have had a documented colonoscopy within the previous three years. If colonoscopy was not&#xD;
      performed within this time frame, the patient will have a colonoscopy as part of the study&#xD;
      protocol.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>October 2015</start_date>
  <completion_date type="Anticipated">July 2021</completion_date>
  <primary_completion_date type="Anticipated">July 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of participants with sporadic (ie not related to FAP or PJS) duodenal/ampullary adenomas</measure>
    <time_frame>24 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of participants with presence and prevalence of colonic polyps</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">177</enrollment>
  <condition>Polyps</condition>
  <arm_group>
    <arm_group_label>Case</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients who have had a previous diagnosis and/or treatment of a duodenal/ampullary polyp at Westmead hospital</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Age matched controls having VCE for OGIB/IDA at Westmead hospital.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Small bowel video capsule endoscopy (VCE) GIVEN/COVIDIEN LTD</intervention_name>
    <description>Cases and controls will have a standard VCE procedure at our institution.</description>
    <arm_group_label>Case</arm_group_label>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Cases - Patients who were diagnosed with or underwent resection of a duodenal&#xD;
             adenoma/ampulloma at Westmead hospital between the years 2005-2014.&#xD;
&#xD;
          -  Controls - Patients undergoing VCE procedure for the evaluation of obscure&#xD;
             gastrointestinal bleeding (OGIB) or Iron deficiency anemia (IDA).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  None&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Bourke, MBBS, FRACP</last_name>
    <role>Principal Investigator</role>
    <affiliation>WSLHD</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Westmead Hospital</name>
      <address>
        <city>Westmead</city>
        <state>New South Wales</state>
        <zip>2145</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Australia</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>June 2, 2015</study_first_submitted>
  <study_first_submitted_qc>June 11, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 12, 2015</study_first_posted>
  <last_update_submitted>March 22, 2021</last_update_submitted>
  <last_update_submitted_qc>March 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Western Sydney Local Health District</investigator_affiliation>
    <investigator_full_name>Professor Michael Bourke</investigator_full_name>
    <investigator_title>Professor of medicine</investigator_title>
  </responsible_party>
  <keyword>duodenal</keyword>
  <keyword>ampulla</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adenoma</mesh_term>
    <mesh_term>Polyps</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

